We are honored to announce that Dr. Hsian-Rong Tseng, a UCLA tenured Professor, will visit BioTReC and deliver a lecture on “Harnessing Liquid Biopsy-Derived Molecular Signatures for Solid Tumor Management” in NBRP on July 2, 2024.
Professor Tseng leads advancements in in vitro diagnostics (IVD) in oncology and perinatology. He founded CytoLumina Technologies Corp. and Eximius Diagnostics, with products like NanoVelcro Chips and an FDA-designated breakthrough Liver Cancer Test. Professor Tseng will present on the latest advancements in "liquid biopsy" techniques. This innovative approach offers a less invasive alternative to traditional cancer diagnosis and prenatal testing, utilizing circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (EVs) to gain critical insights into cancer biology and disease progression.
Don't miss this opportunity to gain insights into cutting-edge technologies developed at the UCLA Liquid Biopsy Laboratory, which are paving the way for more precise and non-invasive diagnostic methods. Please find the lecture information attached and below:
Time: 14:00-16:00, Tuesday, July 2, 2024
Venue: Rm 212, Bldg. C, NBRP
Speaker: Professor Hsian-Rong Tseng
Moderator: Director Han-Chung Wu
Registration: https://forms.gle/9SJELDC9L7GUj8K3A
Lecture language: English
